home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Sapphire Collection
/
Software Vault (Sapphire Collection) (Digital Impact).ISO
/
cdr14
/
med9410l.zip
/
M94A1899.TXT
< prev
next >
Wrap
Text File
|
1994-10-24
|
2KB
|
35 lines
Document 1899
DOCN M94A1899
TI Issues in the development of collaborative programs.
DT 9412
AU Belfer M; Substance Abuse and Mental Health Services Admin, Rockville,
MD; 20857.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):426 (abstract no. PD0313). Unique
Identifier : AIDSLINE ICA10/94370676
AB With the recognition of HIV/AIDS as a major problem for injecting and
non-injecting substance users, health care programs have a heightened
interest in substance abuse treatment in the context of primary health
care. The Substance Abuse and Mental Health Services Administration
supports a number of collaborative projects that demonstrate models for
the provision of substance abuse treatment in primary health care
settings. This presentation will not focus on specific models, but
rather highlight the problems associated with the development of these
collaborative programs. The presentation will describe the planning
process at the highest levels of governmental planning, followed by a
description of the complex fiscal and administrative problems associated
with program implementation. The discussion will detail key points to
consider in determining the primary locus for health care delivery among
injecting and non-injecting drug users, the special funding
considerations in the development of such programs (such as long-term
funding needs vs. acute care concerns), the competition among providers,
and the model of maximum benefit to those diagnosed with AIDS.
DE Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/THERAPY/
TRANSMISSION Delivery of Health Care/*ORGANIZATION & ADMIN Human HIV
Infections/*PREVENTION & CONTROL/TRANSMISSION *Interinstitutional
Relations National Institute of Mental Health (U.S.) Substance Abuse
Substance Abuse, Intravenous United States MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).